Academic Journal
View in EDS
HTML Full Text

A single-dose, randomized crossover study in healthy Chinese subjects to evaluate pharmacokinetics and bioequivalence of two capsules of calcium dobesilate 0.5 g under fasting and fed conditions.

Bibliographic Details
Title: A single-dose, randomized crossover study in healthy Chinese subjects to evaluate pharmacokinetics and bioequivalence of two capsules of calcium dobesilate 0.5 g under fasting and fed conditions.
Authors: Liu Y; Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, China.; Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, China., Cheng J; Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, China.; Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, China., Liang L; Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, China.; Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, China., Qian W; Shanghai Zhaohui Pharmaceutical Co., Ltd., Shanghai, China., Ou M; Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, China.; Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, China., Zhang M; Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, China.; Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, China., Wang Y; Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, China.; Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, China., Wang Y; Shanghai Zhaohui Pharmaceutical Co., Ltd., Shanghai, China., Peng K; Shanghai Center of Biomedicine Development, Shanghai, China., Jia J; Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, China.; Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, China.
Source: PloS one [PLoS One] 2023 Apr 21; Vol. 18 (4), pp. e0284576. Date of Electronic Publication: 2023 Apr 21 (Print Publication: 2023).
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Complete
Full text is not displayed to guests.
Accede al texto completo
Description
ISSN:1932-6203
DOI:10.1371/journal.pone.0284576